Ask the Experts: RSV (Respiratory Syncytial Virus)

• 2024

  Log in to bookmark this resource.

  Log in

---

Access Resources

• SummaryEN
• Ask aRCie About This Resource

About

This Q&A explains RSV (Respiratory Syncytial Virus), a common virus causing cold-like symptoms. It can be severe in infants and older adults. There are no specific treatments, only supportive care. Vaccines like Arexvy, Abrysvo, and mResvia help prevent severe cases in older adults and pregnant women to protect newborns. Nirsevimab is a preventive antibody for infants at high risk of RSV complications. The vaccines are effective but may have mild side effects like injection site reactions or fatigue. Proper storage and timing of vaccinations are important for effectiveness, especially during the RSV season from October to March.

---

Tags

Focus Area: Infectious Disease

Audience: Families & Children

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Child, Preschool; Infant, Newborn; Pregnancy Complications, Infectious; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vaccines, Attenuated; Immunization Programs

Institutions: Immunize.org

---

More like this

Dengue - PAHO/WHO None · World Health Organization (WHO), Pan American Health Organization Dengue and Severe Dengue 2024 · World Health Organization (WHO) 6 Things to Know About Dengue 2020 · Pan American Health Organization

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---